Effect of cystathionine beta-synthase variant 844ins68bp and methylenetetrahydrofolate reductase A1298C polymorphisms in xenografts on 5-FU efficacy and doubling time
- 1 September 2006
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 241 (2) , 256-262
- https://doi.org/10.1016/j.canlet.2005.10.022
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Taiho Pharmaceutical
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 18 references indexed in Scilit:
- A practical false discovery rate approach to identifying patterns of differential expression in microarray dataBioinformatics, 2005
- Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patientsPharmacogenetics, 2004
- cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistanceCancer Chemotherapy and Pharmacology, 2004
- Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemiaLeukemia, 2004
- Identifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics, 2003
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994
- Binding of 5-fluorodeoxyuridylate to thymidylate synthase in human colon adenocarcinoma xenograftsEuropean Journal of Cancer and Clinical Oncology, 1986